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OBJECTIVE—Actin cytoskeleton remodeling is known to be
involved in glucose-stimulated insulin secretion (GSIS). We have
observed glucose-stimulated changes at the b-cell basal mem-
brane similar to focal adhesion remodeling in cell migration. This
led us to study the role of two key focal adhesion proteins, focal
adhesion kinase (FAK) and paxillin, in GSIS.
RESEARCH DESIGN AND METHODS—All studies were
performed using rat primary b-cells or isolated islets. Protein
phosphorylation and subcellular localization were determined
by Western blotting and confocal immunoﬂuorescence, respec-
tively. Insulin was measured by radioimmunoassay. Both siRNA
and pharmacological approaches were used to assess the role of
FAK and paxillin in glucose-stimulated focal adhesion remodeling
and insulin secretion.
RESULTS—Glucose stimulation of b-cells in monolayer signiﬁ-
cantly increased phosphorylation of FAK and paxillin as well as
cell surface area. This coincided with the appearance at the basal
membrane of numerous shorter actin ﬁlopodial extensions, con-
taining not only phosphorylated paxillin, FAK, and extracellu-
lar signal–related kinase 1/2 but also two SNARE proteins,
synaptosomal-associated protein 25 and syntaxin 1, indicating in-
volvement in exocytosis. SR7037 completely inhibited this sequence
of events, indicating the requirement of increased cytosolic Ca
2+.
Furthermore, knockdown of paxillin signiﬁcantly decreased GSIS,
as did inhibition of glucose-induced FAK phosphorylation by com-
pound Y15. Key ﬁndings were conﬁrmed in b-cells within the natu-
ral setting of islets.
CONCLUSIONS—Glucose-stimulated remodeling of focal adhe-
sions and phosphorylation of FAK and paxillin are involved in full
development of GSIS, indicating a previously unknown role for
focal adhesion remodeling in pancreatic b-cell function. Diabetes
60:1146–1157, 2011
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early 40 years ago, studies ﬁrst indicated the
presence of microﬁlamentous structures that
impacted stimulated secretion in pancreatic
b-cells (1,2). Filamentous actin (F-actin) in
b-cells was reported to be organized as a dense web be-
neath the plasma membrane (2) and was later shown to
undergo remodeling upon glucose stimulation. In addition,
others reported enhanced secretagogue-induced insulin
secretion in the presence of F-actin disrupting agents (3–7).
Taken together, these reports suggest F-actin remodeling as
a key factor in insulin granule priming and mobilization
through the F-actin web, but the underlying molecular
mechanism and key signaling pathways involved in this
process remain largely unknown.
Two-way signaling between a cell and its surrounding
extracellular matrix (ECM) is highly important for actin
cytoskeleton organization and thereby also for b-cell via-
bility and function (8,9). The majority of the cellular
receptors involved in cell-matrix interactions belong to the
integrin family (10). Studies on rat pancreatic b-cells re-
vealed that a3b1 and a6b1 integrins are highly expressed
on the cell surface (8,11). In addition, both integrins are
receptors for laminin-5, a component of ECM known to
promote rat b-cell function and survival (8,9). The integrin-
mediated physical connection between cell and ECM is not
simply mechanical but also results in the induction of
outside-in integrin-dependent signaling pathways, begin-
ning with tyrosine phosphorylation of the key cytoskeletal
protein focal adhesion kinase (FAK) (12).
FAK is a nonreceptor tyrosine kinase considered to be
a central molecule in integrin-mediated signaling, involved
in cell cycle progression, cell survival, and migration (13).
While the NH2-terminal domain of FAK is important for
interaction with integrins (14), the carboxyl-terminal ty-
rosine (Y) 397 residue constitutes a major phoshorylation
site located in a linker region connecting the regulatory and
central kinase domain. In the inactivated state, this site
and the Src recruitment site, located in the activation loop,
are blocked by the regulatory domain, preventing auto-
phosphorylation of Y397 and the ensuing Src-mediated
phosphorylation of the activation loop (15). While the pre-
cise mechanisms that allow Y397 autophosphorylation and
subsequent steps in FAK activation are not clear, inter-
action with Src results in phosphorylation of multiple other
FAK tyrosine residues, as well as other focal complex-
associated proteins including p130
CAS and paxillin (16–20).
These and several other proteins are, upon integrin en-
gagement with the ECM, constantly recruited to or removed
from and activated or deactivated in dynamic signaling
structures named focal adhesions. This eventually results in
cytoskeletal changes and activation of other downstream
signaling cascades such as the phosphatidylinositol 3-kinase,
Akt, extracellular signal–regulated kinase (ERK)1/2, and
mitogen-activated protein kinase (21) pathways.
In the current study, we show that activated FAK-paxillin
complexes are incorporated into nascent focal adhesions
upon glucose stimulation of primary rat b-cells. Focal ad-
hesion remodeling in response to glucose is Ca
2+-dependent,
rapid, reversible, and linked to the short-term glucose-
induced activation of the ERK1/2 signaling pathway. Finally,
we show here for the ﬁrst time that these glucose-mediated
events are essential for regulated insulin secretion from
b-cells whether in monolayer cultures or within whole islets.
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ORIGINAL ARTICLERESEARCH DESIGN AND METHODS
Reagents and antibodies. The FAK inhibitor 1,2,4,5-benzenetetraamine tet-
rahydrochloride (Y15) was purchased from Sigma-Aldrich (St. Louis, MO). To
visualize F-actin, Alexa Fluor 647-phalloidin was obtained from Invitrogen
(Carlsbad, CA). Primary antibodies (Abs) were as follows: rabbit anti-FAK
polyclonal (p)Ab (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti–
phospho-(Y397)FAK pAb and rabbit anti–phospho-(Y118)paxillin pAb (Invi-
trogen), mouse anti-paxillin monoclonal (m)Ab (BD Transduction Laboratories,
San Jose, CA), rabbit anti-ERK1/2 pAb and rabbit anti–phospho-(T202/Y204)
ERK1/2 pAb (Cell Signaling Technology, Beverly, MA), mouse antiactin mAb
(Millipore, Temecula, CA). Secondary Abs were as follows: donkey anti-rabbit
horseradish peroxidase and sheep anti-mouse horseradish peroxidase (Amersham
Biosciences, Uppsala, Sweden), donkey anti-rabbit Alexa Fluor 488 and donkey
anti-mouse Alexa Fluor 555 (Invitrogen), and 7-amino-4-methylcoumarin-4-acetate
(AMCA)-conjugated donkey anti–guinea pig (Jackson ImmunoResearch Labo-
ratories, West Grove, PA).
Primary rat b-cell puriﬁcation and culture. Rat islet isolation, b-cell
sorting, and monolayer culture on ECM from 804G cells (804G-ECM) were
performed as previously described (22). Intact islets were ﬁrst maintained for
24 h and then studied in suspension culture.
RNAi-mediated silencing of paxillin. Paxillin expression was depleted
by transfecting primary rat b-cells twice with a pool of three different siRNAs
(59-UGGCACAGUCCUGGACCCCTT-39,5 9-CCUCUCUGAGCUGGACCGGTT-39,
and 59-GACAUGGCACCCCGAGCACTT-39; Microsynth, Balgach, Switzerland)
directed against rat paxillin mRNA using Lipofectamine 2000 reagent (Invi-
trogen) according to the manufacturer’s instructions. Transfected cells were
incubated for 72 h to allow for siRNA expression before analysis.
SDS-PAGE and Western blotting. SDS-PAGE and Western blotting were
performed as previously described (5).Western blots were incubated with
the ECL Plus Western Blotting detection system (Amersham Biosciences)
and exposed with the Fujiﬁlm LAS-4000 camera system. Protein band in-
tensities were quantiﬁed by densitometry using Multi Gauge software (ver-
sion 3.0).
Immunoﬂuorescence and confocal microscopy. Immunoﬂuorescence and
confocal microscopy on sorted b-cells in monolayer was performed as pre-
viously described (5). Isolated rat islets were washed in PBS and ﬁxed in 2%
paraformaldehyde, dehydrated, embedded in parafﬁn, and sectioned at 5 mm.
Before immunoﬂuorescence, sections were deparafﬁnized and rehydrated
with a series of alcohol solutions of decreasing concentration. Primary anti-
bodies (guinea pig anti-insulin, rabbit anti-phospho-paxillin, and mouse anti-
actin) and secondary antibodies (AMCA-conjugated anti–guinea pig, Alexa
488–conjugated anti-rabbit, and Alexa 555–conjugated anti-mouse) were di-
luted in PBS and 0.5% BSA, and incubations were performed at room tem-
perature.
Insulin secretion and transferase-mediated dUTP nick-end labeling
assays. Insulin secretion assays were performed as previously described
(5). With transferase-mediated dUTP nick-end labeling assay, cell death was
measured as previously described (23).
FIG. 1. High glucose stimulation potentiates FAK, paxillin (pax), and ERK1/2 phosphorylation in primary rat b-cells and is inhibited by the ERK1/2
inhibitor PD98059. A: Rat b-cells were preincubated for 2 h in the presence of low glucose (2.8 mmol/L) and were further treated for 20 min with
low (2.8 mmol/L) or high (16.7 mmol/L) glucose. Cells were then collected and lysates were analyzed by Western blot with the indicated antibodies.
A representative blot from six independent experiments is shown. B: The relative intensities of the phosphorylated (p) and total protein bands
were quantiﬁed by densitometry and expressed as a ratio. Data presented as fold increase in this ratio for 16.7 vs. 2.8 mmol/L glucose are means 6
SEM from six independent experiments (*P < 0.01 and **P < 0.05). C: After a 2-h preincubation in the presence of low glucose with 10 mmol/L
PD98059 (or DMSO as a negative control), rat b-cells were stimulated for 20 min with high glucose with PD98059 (or DMSO). Cell lysates were
analyzed by Western blot, and the relative intensities of the phosphorylated and total protein bands were quantiﬁed by densitometry and
expressed as a ratio. Ratios were normalized to control high glucose–stimulated cells. Data are means 6 SEM from three independent experiments
(*P < 0.0001 and **P < 0.01).
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diabetes.diabetesjournals.org DIABETES, VOL. 60, APRIL 2011 1147FIG. 2. High glucose results in the accumulation of phospho (p)-FAK, phospho-paxillin, and phospho-ERK1/2 at newly formed focal adhesions in
primary rat b-cells. A:R a tb-cells were preincubated for 2 h in the presence of low glucose (2.8 mmol/L) and were further treated for 20 min with
low (2.8 mmol/L) or high (16.7 mmol/L) glucose. Cells were subsequently ﬁxed and stained for phospho-paxillin (green), total paxillin (red), and
actin (with phalloidin, blue). Right panel: Quantiﬁcation of phospho-paxillin–containing focal adhesions in low- vs. high-glucose conditions. Data
are expressed as number of focal adhesions per micrometer of cell perimeter and are means 6 SEM from four independent experiments (*P <
0.0001). B: After preincubation for 2 h with 2.8 mmol/L glucose, rat b-cells were incubated for 20 min with 2.8 mmol/L glucose (upper panel),
stimulated for 20 min with 16.7 mmol/L glucose (middle panel), or stimulated for 20 min with 16.7 mmol/L glucose and shifted back to 2.8 mmol/L
glucose for 20 min (lower panel). Cells were ﬁxed and stained for phospho-paxillin (green) and actin (blue). C: Rat b-cells were preincubated for
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the experimental conditions was determined by Student t test for unpaired
groups. P values .0.05 were considered signiﬁcant.
RESULTS
Aside from experiments using intact islets when indicated, all
studies were performed using sorted rat primary b-cells cul-
tured in monolayer on a surface coated with 804G-ECM (22).
FAK, paxillin, and ERK1/2 are activated upon glucose
stimulation of rat primary b-cells. To gain insight into
a possible role of FAK and two of its downstream targets,
paxillin and ERK1/2, in glucose-regulated b-cell function,
we studied the phosphorylation status of these proteins in
response to glucose. Phosphorylation of both FAK (Y397)
and paxillin (Y118) was already detectable under basal
conditions but was signiﬁcantly increased following glu-
cose stimulation (20 min), indicating short-term glucose-
mediated activation of these two focal adhesion factors. A
similar effect was observed for ERK1/2 (Fig. 1A and B).
A previous study in the mouse pancreatic b-cell line MIN6
B1 documented the rapid glucose-stimulated activation of
ERK1/2 and subcellular localization of active phospho-
ERK1/2 at newly formed tips of actin ﬁbers (5). Based on
these observations, we used the ERK1/2 inhibitor PD98059
to determine whether ERK1/2 is implicated in the short-
term glucose-induced phosphorylation of FAK and paxillin.
Figure 1C clearly indicates the inhibitory effect of PD98059
on the phosphorylation of both focal adhesion proteins.
Activated FAK, paxillin, and ERK1/2 colocalize in
actin ﬁlopodial extensions upon glucose stimulation.
To determine the main sites of action of phosphorylated
FAK and paxillin, we analyzed the subcellular localization
of the respective activated proteins in conjunction with the
F-actin cytoskeleton by confocal immunoﬂuorescence of
the basal cell surface (deﬁned as the cell membrane in
direct contact with ECM). In b-cells preincubated for 2 h at
2.8 mmol/L glucose, phosphorylated paxillin localized in a
few long ﬁlopodial extensions (Fig. 2A). Upon short-term
glucose stimulation, there was actin cytoskeleton reor-
ganization coinciding with the striking accumulation of
phospho-paxillin at the tips of numerous newly formed,
shorter ﬁlopodia, resembling classical nascent focal adhe-
sions (16.7 mmol/L glucose) (Fig. 2A). Similar morpho-
logical changes were apparent following stimulation with
KCl, phorbol myristic acid (PMA), or glucagon-like pep-
tide (GLP)-1 (data not shown). Quantiﬁcation of these
phospho-paxillin–containing focal adhesions showed a sig-
niﬁcant increase in focal adhesion density in response to
glucose stimulation (Fig. 2A). When such glucose-stimulated
b-cells were shifted back to low glucose, they regained their
basal conformation within 20 min (Fig. 2B), indicating the
dynamic, reversible character of the glucose-mediated
formation of focal adhesions. Shorter stimulations of 5 or
10 min at 16.7 mmol/L glucose resulted in similar changes,
indicating the rapid time course of this glucose-induced re-
modeling process (data not shown).
Further analysis of these ﬁlopodial extensions of glucose-
stimulated b-cells revealed the colocalization of activated
phospho-FAK (Fig. 2C) and phospho-ERK1/2 (Fig. 2C)
along with paxillin, indicating that the previously de-
scribed sites of short-term glucose-dependent ERK1/2 ac-
tivation at the tips of actin ﬁbers (5) correspond to the
nascent focal adhesions formed in response to glucose.
Moreover, (co)localization of phospho-paxillin with two
SNARE proteins, synaptosomal-associated protein (SNAP)-25
and syntaxin 1, at these glucose-induced ﬁlopodial exten-
sions (Fig. 2D) suggested a functional role for these sites in
regulated insulin secretion.
Short-term glucose-stimulated b-cell spreading coincides
with focal adhesion remodeling. Rat islet b-cells at-
tached on ECM spread in response to high glucose over
24 h (8). To assess the effect of acute exposure, b-cells
2 h in the presence of low glucose (2.8 mmol/L) and were then stimulated for 20 min with 16.7 mmol/L glucose. Cells were ﬁxed and stained with the
indicated antibodies. Parts of the merged images (red boxes) are shown at higher magniﬁcation (right panels) to clearly visualize the presence of
paxillin (red) with phospho-FAK and phospho-ERK1/2, respectively (green), in actin-containing ﬁlopodia (blue). White regions indicate colocal-
ization. D: Cells were treated as described above and were stained with the indicated antibodies. All images are fully representative of three to
four independent experiments. (A high-quality digital representation of this ﬁgure is available in the online issue.)
FIG. 3. Glucose-stimulated focal adhesion remodeling is accompanied
by progressive b-cell spreading. A: Rat primary b-cells were pre-
incubated for 2 h with 2.8 mmol/L glucose and then stimulated with 16.7
mmol/L glucose. Cells were ﬁxed at the indicated times and stained with
Evans blue, and cell surface areas were quantiﬁed using AxioVision
4.7.2. Data are means 6 SEM from four independent experiments; *P <
0.05 and **P < 0.01 vs. control cells kept at 2.8 mmol/L glucose (0 min).
a.u., arbitrary units. B: Rat primary b-cells were preincubated for 2 h
with 2.8 mmol/L glucose and then treated for 20 min with 2.8 mmol/L or
16.7 mmol/L glucose. Cells were then ﬁxed and stained for phospho-
paxillin (green) and actin (red). Nuclei (blue) were stained with
Hoechst 33342. Three-dimensional reconstructions from confocal image
stacks were performed using Imaris (version 4.0). Pictures are repre-
sentative of multiple images from a single experiment. (A high-quality
digital representation of this ﬁgure is available in the online issue.)
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cose and cell surface was measured. As shown in Fig. 3A,
there was already a signiﬁcant increase in spreading after
20 min, with a further increase at 60 min. Furthermore,
three-dimensional reconstruction of confocal stack images
clearly illustrates that glucose-stimulated cell spreading is
accompanied by the appearance of the phospho-paxillin–
containing ﬁlopodial extensions previously described
(Fig. 3B).
Glucose-stimulated Ca
2+ inﬂux is required for
activation and translocation of FAK and paxillin. A
selective blocker of voltage-gated Ca
2+ channels, SR7037,
was used to establish the need for increased cytosolic Ca
2+
in glucose-induced focal adhesion remodeling and FAK,
paxillin, and ERK1/2 activation. Having conﬁrmed the pre-
viously described inhibitory effect of SR7037 on glucose-
stimulated insulin secretion (GSIS) (22) (data not shown),
we demonstrated that SR7037 markedly decreased short-
term glucose-stimulated formation of phospho-paxillin–
containing ﬁlopodial extensions (Fig. 4A)w h i c hw a s
validated by quantiﬁcation of these structures (Fig. 4A).
Furthermore, Western blot analysis revealed that glucose-
induced phosphorylation of FAK, paxillin, and ERK1/2 was
inhibited by SR7037 (Fig. 4B).
FAK inhibition reduces glucose-stimulated focal
adhesion remodeling and insulin secretion. In view
of the important role for proteins such as FAK and paxillin
in ECM-integrin-actin cytoskeleton interactions and the
data presented above, we hypothesized that the activated
FAK-paxillin-ERK1/2 complexes located at the newly formed
ﬁlopodia might mediate GSIS. To test this hypothesis, we
ﬁrst examined whether FAK activation represents a regu-
latory step in glucose-stimulated phosphorylation of pax-
illin and ERK1/2, using compound Y15, which speciﬁcally
inhibits FAK-Y397 autophosphorylation (24,25). As shown
in Fig. 5A, glucose-induced phosphorylation of FAK, paxillin,
and ERK1/2 is signiﬁcantly inhibited by Y15. This indicates
that glucose-induced activation of ERK1/2 is at least partially
dependent on FAK activation, whereas we showed (de-
scribed above) that the opposite is also true, with FAK ac-
tivation being inhibited by the ERK1/2 inhibitor PD98059.
These two observations are compatible with earlier evidence
FIG. 4. SR7037, a selective L-type Ca
2+ channel blocker, decreases glucose-induced focal adhesion remodeling and glucose-stimulated phosphor-
ylation of FAK, paxillin, and ERK1/2 in primary rat b-cells. A, left panel: Rat b-cells were preincubated for 2 h in the presence of low glucose (2.8
mmol/L) and were further stimulated for 20 min with high (16.7 mmol/L) glucose with 1 mmol/L SR7037 (or DMSO as a negative control). Cells
were ﬁxed and stained for phospho-paxillin (green), total paxillin (red), and actin (with phalloidin, blue). All images are fully representative of
three independent experiments. Right panel: Quantiﬁcation of phospho-paxillin–containing focal adhesions (FAs). Data are expressed as number
of focal adhesions per micrometer of cell perimeter normalized to control high glucose–stimulated cells and are means 6 SEM from three in-
dependent experiments. *P < 0.001 vs. control-stimulated cells. B:R a tb-cells were treated as described above. Cell lysates were analyzed by
Western blot with the indicated antibodies, and relative intensities of the phosphorylated and total protein bands were quantiﬁed by densitometry
and expressed as a ratio. Ratios were normalized to control high glucose–stimulated cells. Data are means 6 SEM from three independent
experiments (*P < 0.0001 and **P < 0.05). (A high-quality digital representation of this ﬁgure is available in the online issue.)
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the presence of low glucose (2.8 mmol/L) with Y15 (1 mmol/L or DMSO) and were further stimulated for 20 min with high (16.7 mmol/L) glucose
in the presence of Y15 (1 mmol/L or DMSO). Cell lysates were analyzed by Western blot with the indicated antibodies, and the relative intensities
of the phosphorylated and total protein bands were quantiﬁed by densitometry and expressed as a ratio. Ratios were normalized to control high
glucose–stimulated cells. Data are means 6 SEM from three independent experiments (*P < 0.001 and **P < 0.01). pax, paxillin. B: Quantiﬁcation
of phospho-paxillin–containing focal adhesions (FAs) in primary b-cells after 20 min stimulation with 16.7 mmol/L glucose with or without 1 mmol/
L compound Y15. Data are expressed as number of focal adhesions per micrometer of cell perimeter normalized to control high glucose–stimulated
cells and are means 6 SEM from three independent experiments. *P < 0.01 vs. control-stimulated cells. C: b-Cells were incubated for 2 h with 2.8
mmol/L glucose with compound Y15 (or DMSO) and then stimulated for 20 min with 16.7 mmol/L glucose with or without compound Y15. Cells were
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adhesion remodeling (26,27).
Immunoﬂuorescence experiments revealed that treatment
with Y15 resulted in a marked reduction in glucose-induced
translocation and incorporation of phospho-paxillin in newly
formed short focal adhesions (data not shown), which was
conﬁrmed by quantiﬁcation of the latter (Fig. 5B). Fur-
thermore, Y15 signiﬁcantly decreased short-term glucose-
induced b-cell spreading (Fig. 5C).
Finally, we investigated the effect of inhibition of FAK
phosphorylation on GSIS. In the presence of compound
Y15, insulin secretion in response to glucose was de-
creased by 76.9 6 5.4% (P , 0.001), whereas basal secre-
tion was 4.4-fold increased (from 0.16 6 0.02 to 0.72 6
0.20%; P , 0.05) (Fig. 5D). This decrease was sustained
throughout both early (corresponding to ﬁrst phase) and
late (second phase) periods of the stimulatory period
(Fig. 5E). There was also a 27.3 6 8.4% (P , 0.05) decrease
in the total (secreted plus intracellular) insulin content
after compound Y15 treatment (data not shown), which
might explain the increase in basal insulin secretion (as a
fraction of cell content). The Y15-mediated inhibition of
glucose-induced focal adhesion formation was reversible
(Fig. 5F), and this was attended by the partial recovery of
GSIS (Fig. 5F).
RNAi-mediated knockdown of FAK and paxillin
inhibits GSIS. Although inhibition of FAK activation by
Y15 indicated its involvement in focal adhesion remodeling
and insulin secretion in response to glucose, there is al-
ways the risk of unexpected nonspeciﬁc or off-target
effects when pharmacological agents are used. We used
two different strategies to overcome this. For the ﬁrst
approach, RNAi-mediated silencing of FAK was performed
in MIN6 B1 cells, resulting in an ;40% reduction in the
level of FAK, which was associated with a 40.2 6 2.3%
(P , 0.001) decrease in GSIS (data not shown).
The second series of experiments involved knockdown
of paxillin in primary rat b-cells using siRNA duplexes. We
have shown previously that siRNA duplexes can be suc-
cessfully introduced into the vast majority of primary
b-cells using standard transfection procedures (28). Pax-
illin knockdown (Fig. 6A) did not affect b-cell death
(Fig. 6B) but did, similar to Y15, result in a signiﬁcant
inhibition of glucose-induced ERK1/2 phosphorylation
(Fig. 6C), focal adhesion formation (Fig. 6D), and b-cell
spreading (Fig. 6E). Furthermore, silencing of paxillin also
decreased GSIS by 60.0 6 5.7% (P , 0.05) (Fig. 6F).
However, in contrast to Y15, paxillin knockdown did not
affect total insulin content (data not shown) or basal se-
cretion. Finally, Table 1 illustrates that silencing of paxillin
also signiﬁcantly inhibited KCl-, PMA, and GLP-1–stimulated
insulin secretion.
Focal adhesion remodeling in intact rat islets. Be-
cause all the former experiments were performed using
sorted b-cells in two-dimensional monolayer culture on
804G-ECM, a less physiological setting than that of the
three-dimensional micro-organ, we also veriﬁed b-cell be-
havior within intact islets. A single preliminary experiment
conﬁrmed glucose-induced phosphorylation of FAK at
Y397 that was inhibited by treatment of the islets with
compound Y15. However, short-term glucose stimulation
did not result in increased phosphorylation of paxillin or
ERK1/2 (data not shown). Furthermore, and most signiﬁ-
cantly, three dimensional reconstruction of immunoﬂuo-
rescence confocal stack images of semithin sections of
differently treated intact islets (Fig. 7A) revealed the
glucose-induced concentration of phospho-paxillin in well-
deﬁned patches. This glucose-induced effect was inhibited
by treatment of the islets with compound Y15 (Fig. 7A). The
focal adhesion–like ﬁlopodial extensions and actin stress
ﬁbers observed in two-dimensional b-cell monolayers in
response to glucose were not seen in intact islets, but this
was anticipated for cells in such a three-dimensional con-
ﬁguration (discussed further below). Finally, we observed
t h a tF A Ki n h i b i t i o nr e s u l t e di nas i g n i ﬁcant decrease (64.5 6
16.4%; P , 0.05) in GSIS from whole islets (Fig. 7B). Taken
together, these results suggest that, notwithstanding the
anticipated differences in glucose-induced physical alter-
ations in b-cells in two-dimensional monolayers versus in
whole islets, FAK signaling also appears to play an im-
portant role in regulated insulin secretion from b-cells
present in the more physiological setting of the three-
dimensional micro-organ.
DISCUSSION
Cellular attachment, spreading, and migration involve fo-
cal adhesion remodeling (29) that is associated with re-
organization of cytoskeletal structures and activation of
intracellular signaling pathways. Focal contact sites thereby
provide both a structural link between the ECM and cyto-
skeletal proteins as well as initiation points for outside-in
signaling leading to changes in cell activity and gene
expression (30–32). In the current study, we describe
short-term glucose-stimulated changes at the b-cell basal
membrane that are reminiscent of focal adhesion remod-
eling at ﬁlopodia during cell migration and show these to
be involved in GSIS.
Both FAK and paxillin have been identiﬁed as focal
adhesion proteins that become phosphorylated in re-
sponse to ECM adhesion (33). The best-characterized FAK
phosphorylation event is Y397 autophosphorylation, cru-
cial for its kinase activity (34). Regarding paxillin, Y118 has
been shown to be the major tyrosine phosphorylation site
involved in focal contact turnover and cell motility (20,35).
The observation that short-term glucose stimulation of
b-cells induces increased phosphorylation of FAK and
paxillin at these particular sites thus indicates a possible
role for these proteins in b-cell function.
Translocation of FAK and paxillin into focal adhesions
has been found to be critical for cell spreading and mi-
gration but not for cell adhesion (36,37). In epithelial cells
induced to migrate, immunolabeling with phospho-tyrosine
then ﬁxed and stained with Evans blue and cell surface areas were quantiﬁed using AxioVision 4.7.2. Cell areas were normalized to control high
glucose–stimulated cells. Data are expressed as means 6 SEM from three independent experiments; *P < 0.01 vs. control-stimulated cells. D:R a t
primary b-cells were preincubated for 2 h with 2.8 mmol/L glucose with compound Y15 (or DMSO). Cells were then incubated with low (2.8 mmol/L,
basal) followed by high (16.7 mmol/L, stimulated) glucose with or without Y15 for 1 h. Insulin secretion is expressed as a percentage of total insulin
cell content. Data are means 6 SEM from three independent experiments. *P < 0.001 and **P < 0.05 vs. control at the same glucose concentration.
E: Cells were incubated as described above but were stimulated with high glucose with Y15 (or DMSO) for the indicated times. Data are expressed
as means 6 SEM from four independent experiments. *P < 0.05 vs. Y15-treated cells. F: Rat b-cells were preincubated for 2 h with 2.8 mmol/L
glucose with or without compound Y15 (preincubation conditions). Cells were then stimulated with 16.7 mmol/L glucose with or without Y15
(stimulation conditions). Upper panel: Cells were ﬁxed and phospho-paxillin–containing focal adhesions were quantiﬁed and expressed as number
per micrometer of cell perimeter normalized to control high glucose–stimulated cells. Lower panel: Insulin secretion was normalized to control
high glucose–stimulated cells. Data are means 6 SEM from three independent experiments. *P < 0.05 and **P < 0.001.
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calized along the cell periphery and connected to actin
stress ﬁbers in focal adhesions (38). In agreement with
these ﬁndings, we observed, prior to cell spreading, the
glucose-induced formation of multiple nascent focal adhe-
sions containing both phosphorylated FAK (Y397) and pax-
illin (Y118) in close proximity. Furthermore, we conﬁrmed
the basal membrane–proximal localization of phospho-
ERK1/2 at the tips of actin ﬁlaments in glucose-stimulated
b-cells (5) and now demonstrate the colocalization of
phospho-ERK1/2 with paxillin at these particular sites that
we deﬁne as ﬁlopodial focal adhesions.
Glucose stimulation of b-cells results in an increase of
intracellular Ca
2+ that is known to be a key trigger for
insulin secretion. SR7037, a selective L-type Ca
2+ channel
blocker, inhibited glucose-stimulated phosphorylation of
ERK1/2, FAK, and its substrate paxillin, showing these
events to be dependent on Ca
2+ inﬂux. This is in accordance
FIG. 6. siRNA-mediated depletion of endogenous paxillin (Pax) signiﬁcantly attenuates glucose-stimulated focal adhesion remodeling and insulin
secretion in primary rat b-cells. b-Cells were transfected with either scrambled (Scr) siRNA or a cocktail of three siRNAs speciﬁc for rat paxillin
and studied 72 h later. A: Paxillin knockdown was veriﬁed by Western blot with equal loading conﬁrmed with an antiactin antibody. A repre-
sentative blot from three independent experiments is depicted (left panel), and paxillin-to-actin ratios were quantiﬁed by densitometry (right
panel). B: Cell death (apoptosis plus necrosis) measured using the transferase-mediated dUTP nick-end labeling assay. C: siRNA-transfected
b-cells were incubated for 2 h with 2.8 mmol/L glucose and stimulated for 20 min with 16.7 mmol/L glucose. Lysates were analyzed by Western blot
with the indicated antibodies, and the relative intensities of the phosphorylated and total protein bands were quantiﬁed by densitometry and
expressed as a ratio. Ratios were normalized to scrambled siRNA-transfected cells. D and E: siRNA-transfected b-cells were incubated as described
above. Cells were then ﬁxed and stained with either phospho-paxillin and actin or Evans blue. Both phospho-paxillin–containing focal adhesions
and cell surface areas were quantiﬁed and normalized to scrambled siRNA-transfected cells. F: siRNA-transfected primary b-cells were incubated
with low (2.8 mmol/L) followed by high (16.7 mmol/L) glucose for 1 h, and insulin release was monitored and expressed as a percentage of total cell
content. Data are means 6 SEM from three independent experiments. *P < 0.05 and **P < 0.001 vs. scrambled siRNA-transfected cells.
D. RONDAS, A. TOMAS, AND P.A. HALBAN
diabetes.diabetesjournals.org DIABETES, VOL. 60, APRIL 2011 1153with previous studies in other cell types reporting induced
FAK autophosphorylation and kinase activity driven by a
physiological rise in intracellular Ca
2+ concentration (39–
41). Moreover, earlier reported Ca
2+-dependent reversibility
of FAK activation and cell spreading (40) coincides with the
reversible character of the glucose-induced formation of
nascent focal adhesions in b-cells, suggesting an important
role for Ca
2+ in the dynamic regulation of cellular fo-
cal adhesions during short-term glucose stimulation. These
results, together with the previously described inhibitory
effect of SR7037 on GSIS (22), suggest a link thus far un-
suspected between focal adhesion remodeling and regu-
lated insulin secretion in b-cells. Note, however, that the
observed changes in FAK and paxillin phosphorylation were
small compared with the drastic inhibition of GSIS by
SR7037, suggesting that the activation of FAK and paxillin is
only partially Ca
2+ dependent and that this in combination
with the inhibition of other Ca
2+-dependent ERK1/2 activa-
tion mechanisms by SR7037 results in a signiﬁcant inhibition
of ERK1/2 and GSIS.
To conﬁrm the possible involvement of FAK in GSIS, we
performed both RNAi-mediated FAK knockdown (in MIN6
B1 cells) and pharmacological inhibition of FAK activity by
compound Y15 (25). The latter was identiﬁed as a speciﬁc
inhibitor of Y397-FAK phosphorylation by using a structure-
based approach combining functional testing and molecular
docking of the three-dimensional structure of numerous
small molecule compounds into the structural pocket of
the Y397 site. Speciﬁcity of this inhibitory compound has
been further veriﬁed using various in vitro kinase assays
(24). Both strategies demonstrated a link between the level
and activity of FAK, focal adhesion remodeling, ERK1/2
pathway activation, and GSIS in b-cells. We further conﬁrm
this by siRNA-mediated silencing of paxillin, resulting in a
signiﬁcant inhibition of glucose-induced ERK1/2 phosphor-
ylation, focal adhesion formation, b-cell spreading, and in-
sulin secretion (without affecting total insulin content or
cell survival). These results, in combination with the dem-
onstrated colocalization of activated FAK, paxillin, and
ERK1/2 at ﬁlopodial focal adhesions at the basal membrane
of glucose-stimulated b-cells, indicate that glucose-induced
focal adhesion remodeling plays a crucial role in GSIS.
Furthermore, the inhibitory effect of paxillin knockdown on
KCl-, PMA-, and GLP-1–stimulated insulin secretion in-
dicates that paxillin acts at a distal step in the insulin
secretory machinery. A comparable inhibitory effect of
compound Y15 on both the early and late phases of insulin
secretion corroborates this but could also indicate that
both the initial size of the readily releasable pool and the
following supply of secretory vesicles to this pool are
affected by blocking FAK activation. However, as it cannot
be excluded by these experiments that paxillin RNAi also
impacts insulin secretion by other, indirect ways (e.g., by
modulating expression of key b-cell genes), this is some-
thing that will need to be studied in the future.
In view of these observations, we propose that glucose-
induced autophosphorylation and thereby activation of
FAK is mediated by increased intracellular Ca
2+ concen-
trations. Activated FAK then phosphorylates its direct
substrate paxillin, which may act as an adaptor protein
through FAK to increase linkage between activated integ-
rin complexes and the actin cytoskeleton. We hypothesize
that these events and the coinciding actin cytoskeletal
reorganization are essential for full development of GSIS,
acting at a late stage in exocytosis. This is supported by
the (co)localization of phospho-paxillin with SNAP-25 and
syntaxin 1 in glucose-induced focal adhesions because
these two SNARE proteins are well known to play a pivotal
role during vesicle fusion in the process of regulated in-
sulin exocytosis, with documented links to the b-cell actin
cytoskeleton (4,42). In addition, as observed in CHO-K1
cells (43), these data might also suggest a role for SNARE-
mediated membrane trafﬁcking in glucose-induced focal
adhesion signaling in b-cells.
Our results also point toward the FAK-paxillin complex
as the mediator of actin remodeling–induced local phos-
phorylation of ERK1/2 at focal adhesions after glucose
stimulation of b-cells. FAK-Src–mediated tyrosine phos-
phorylation of paxillin is known to result in association of
inactive ERK with its upstream effectors mitogen-activated
protein kinase and Raf forming a scaffold and facilitating
ERK activation at focal adhesions (27), offering a molecu-
lar basis for our own observations. This pathway is self-
enhanced; activated ERK can then phosphorylate paxillin
itself, which will increase its association to FAK and in
turn enhance FAK activation (26,27), consistent with our
data using the ERK1/2 inhibitor PD98059. This short-term
ERK1/2-triggered phosphorylation of FAK and paxillin
correlates with earlier studies showing that ERK1/2 is in-
volved in early-phase GSIS (5). Note, however, the differ-
ences in the level of glucose-induced phosphorylation
between FAK/paxillin and ERK1/2 that conﬁrm the in-
volvement of additional signaling pathways in glucose-
induced ERK1/2 activation. Glucose-activated ERK1/2 has
previously been shown to be involved in the regulation of
insulin secretion and coincides temporally with transient
glucose-induced actin cytoskeleton remodeling (4,5). In
addition, activation of FAK and paxillin could also poten-
tiate GSIS in b-cells through ERK1/2-mediated phosphor-
ylation of synapsin 1 (44), a protein believed to function as
TABLE 1













by Pax RNAi (%) P
5 — 60 0.27 6 0.07 0.17 6 0.07 40.5 6 8.8 0.01
5 100 nmol/L GLP-1 60 2.12 6 0.74 1.32 6 0.47 36.3 6 4.8 0.002
2.8 30 mmol/L KCl 20 0.27 6 0.08 0.12 6 0.04 55.3 6 2.3 2.10
25
2.8 100 nmol/L PMA 60 1.45 6 0.52 1.12 6 0.53 30.3 6 9.5 0.02
Data are means 6 SEM from three to four independent experiments. siRNA-transfected primary rat b-cells were preincubated under basal
conditions (2.8 mmol/L glucose) and subsequently incubated for 1 h with 2.8 mmol/L glucose followed by either 1 h with 5 mmol/L glucose,
GLP-1 (plus 5 mmol/L glucose), or PMA (plus 2.8 mmol/L glucose) or 20 min with KCl (plus 2.8 mmol/L glucose). Secretion is expressed as
percentage of total insulin (secreted plus cell content) and percent decrease in stimulated insulin secretion compared with scrambled (Scr)
siRNA-transfected cells.
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1154 DIABETES, VOL. 60, APRIL 2011 diabetes.diabetesjournals.orgFIG. 7. Effect of FAK inhibition on insulin secretion and subcellular localization of phospho-paxillin in b-cells in intact rat islets. A: Isolated islets
were incubated for 2 h with 2.8 mmol/L glucose with or without 1 mmol/L Y15 and were then stimulated for 20 min with 2.8 mmol/L glucose, 16.7
mmol/L glucose, or 16.7 mmol/L glucose with Y15. Islet sections (5 mm) were then ﬁxed and stained with the indicated antibodies. Three-
dimensional reconstruction from confocal image stacks was performed using Imaris (version 7.2). The upper three rows illustrate a top view and
the lower row a side view of reconstructions of the same set of stacks from a single islet section for each given condition. In the side view images,
actin staining (red) is represented by reconstructed isosurfaces. Scale bars = 2 mm. Images are representative of multiple sections from two
independent experiments. B: Isolated islets were ﬁrst preincubated for 2 h at 2.8 mmol/L glucose and then incubated for 1 h each at 2.8 mmol/L
followed by 16.7 mmol/L glucose in the continued presence of 1 mmol/L compound Y15 (or DMSO). Insulin secretion is expressed as a percentage of
total insulin cell content, normalized to control stimulated islets. Data are means 6 SEM from three independent experiments. *P < 0.05 vs.
control-stimulated islets. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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toskeleton. Synapsin 1 phosphorylation may result in the
release of secretory granules from the cytoskeleton net-
work and mobilization from a passive reserve pool to an
active releasable pool (45). Further experiments outside
the scope of this study will be required to verify this
functional hypothesis.
To conﬁrm our central hypothesis in the more physio-
logical setting of the three-dimensional micro-organ, ad-
ditional experiments were performed on whole islets.
These experiments revealed clear differences in behavior
between cells in two-dimensional culture and three-
dimensional aggregates. b-Cells within islets did not show
clearly evident actin stress ﬁbers, and focal adhesions were
not present in ﬁlopodial extensions, which was entirely
expected based on the comparison of these structures
in other cell types in two-dimensional versus three-
dimensional assemblies (46). However, glucose induced
phosphorylation of FAK and clearly changed phospho-
paxillin subcellular localization in b-cells within islets,
which was prevented by compound Y15 which also in-
hibited GSIS from whole islets. In contrast, in a single
preliminary experiment paxillin and ERK1/2 phosphoryla-
tion in whole islets were not affected by glucose. This
could be due to opposite glucose-induced changes in other
islet cell types or higher basal phosphorylation levels of
both paxillin and ERK1/2 in islets compared with sorted
b-cells. The latter could once again be explained by the
mixed contribution of all islet cells in Western blots of
whole islet proteins but also possibly by the presence of
glucagon secreted by a-cells because ERK1/2 is a known
substrate of protein kinase A that would be activated by
increased cAMP in response to glucagon (47). Finally, we
cannot exclude that the three-dimensional organization of
cells within islets impacts the phosphorylation of these
proteins involved in inside-out and outside-in cell signaling.
In conclusion, the current study shows for the ﬁrst
time the existence of short-term glucose-mediated, Ca
2+-
dependent activation of the key focal adhesion proteins,
FAK and paxillin, in pancreatic b-cells. Most importantly,
this focal adhesion remodeling process appears to be an
important player in GSIS, providing a novel additional
component to the complex molecular machinery under-
lying this key event in glucose homeostasis. Despite the
well-recognized differences in behavior between b-cells in
two-dimensional culture and whole islets, it was reassuring
to be able to conﬁrm the most important features of this
novel component of b-cell–regulated exocytosis using in-
tact islets. Further studies are needed to determine the
exact molecular events downstream glucose-induced ac-
tivation of FAK and paxillin that impact insulin secretion
and whether perturbation of this new pathway contributes
toward b-cell dysfunction in type 2 diabetes.
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